In 2018, Dr. David received his Medical Degree from the University of Virginia School of Medicine in Charlottesville, Virginia. He was the leader of the Otolaryngology-Head and Neck Surgery Interest Group there, and he was involved in research projects focused on insulin-like growth factor receptor (IGFR) pathway in head an neck squamous cell carcinoma tumor progression and therapeutics as well as a project focused on determining the safety and use of proton pump inhibitors (PPIs) in laryngopharyngeal reflux.
In 2018, Dr. David received his Medical Degree from the University of Virginia School of Medicine in Charlottesville, Virginia. He was the leader of the Otolaryngology-Head and Neck Surgery Interest Group there, and he was involved in research projects focused on insulin-like growth factor receptor (IGFR) pathway in head an neck squamous cell carcinoma tumor progression and therapeutics and several projects regarding the clinical outcomes of Mohs defect reconstruction.